1. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery. Thoracic and cardiovascular surgery in Japan during 2014: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2016;64:665-697.Committ
2. Yoneyama F, Okamura T, Takigiku K, et al. Novel Urinary Biomarkers for Acute Kidney Injury and Prediction of Clinical Outcomes After Pediatric Cardiac Surgery. Pediatr Cardiol. 2020;41:695-702.
3. Delaney JW, Moltedo JM, Dziura JD, et al. Early postoperative arrhythmias after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2006;131:1296-1300.
4. Rekawek J, Kansy A, Miszczak-Knecht M, et al. Risk factors for cardiac arrhythmias in children with congenital heart disease after surgical intervention in the early postoperative period. J Thorac Cardiovasc Surg. 2007;133:900-904.
5. Valsangiacomo E, Schmid ER, Schüpbach RW, et al. Early postoperative arrhythmias after cardiac operation in children. Ann Thorac Surg. 2002;74:792-796.
6. Pfammatter JP, Wagner B, Berdat P, et al. Procedural factors associated with early postoperative arrhythmias after repair of congenital heart defects. J Thorac Cardiovasc Surg. 2002;123:258-262.
7. Makhoul M, Oster M, Fischbach P, Das S, Deshpande S. Junctional ectopic tachycardia after congenital heart surgery in the current surgical era. Pediatr Cardiol. 2013;34:370-4.
8. Dodge-Khatami A, Miller OI, Anderson RH, et al. Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects. Eur J Cardiothorac Surg. 2002;21:255-259.
9. Entenmann A, Michel M, Herberg U, et al. Management of postoperative junctional ectopic tachycardia in pediatric patients: a survey of 30 centers in Germany, Austria, and Switzerland. Eur J Pediatr. 2017;176:1217-1226.
10. Anjan S. Batra, Nivedita Mohari. Junctional ectopic tachycardia: Current strategies for diagnosis and management. Progress in Pediatric Cardiology. 2013;35: 49-54.
11. Kadam SV, Tailor KB, Kulkarni S, et al. Effect of dexmeditomidine on postoperative junctional ectopic tachycardia after complete surgical repair of tetralogy of Fallot: A prospective randomized controlled study. Ann Card Anaesth. 2015;18:323-328.
12. Tobias JD, Chrysostomou C. Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient. Pediatr Cardiol. 2013;34:779-785.
13. E Amrousy DM, Elshmaa NS, El-Kashlan M, et al. Efficacy of Prophylactic Dexmedetomidine in Preventing Postoperative Junctional Ectopic Tachycardia After Pediatric Cardiac Surgery. J Am Heart Assoc. 2017;6. pii: e004780. doi: 10.1161/JAHA.116.004780.
14. Gautam NK, Turiy Y, Srinivasan C. Preincision Initiation of Dexmedetomidine Maximally Reduces the Risk of Junctional Ectopic Tachycardia in Children Undergoing Ventricular Septal Defect Repairs. J Cardiothorac Vasc Anesth. 2017;31:1960-1965.
15. Li, Zhang C, Dai D, et al. Efficacy of dexmedetomidine in prevention of junctional ectopic tachycardia and acute kidney injury after pediatric cardiac surgery: A meta- analysis. Congenit Heart Dis. 2018;13:799-807.
16. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Circulation. 1991;84:1831-1851.
17. American Heart Association. Pediatric Advanced Life Support Provider Manual.
18. 小児循環器学会「小児不整脈の診断・治療に関する検討委員会」. 小児不整脈の診断・治療ガイドライン
19. Sugiyama A, Satoh Y, Ishida Y, et al. Pharmacological and electrophysiological characterization of junctional rhythm during radiofrequency catheter ablation of the atrioventricular node: possible involvement of neurotransmitters from autonomic nervous system. Circ J. 2002;66:696-701.
20. Sezai A, Minami K, Nakai T, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thoracic Cardiovasc Surg. 2011;141:1478-1487.
21. Sezai A, Nakai T, Hata M, et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. J Thorac Cardiovasc Surg. 2012;144:1241-1248.
22. Sakamoto A, Kitakaze M, Takamoto S, et al. Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study). Circ J. 2012;76:1097-1101.
23. Nagai R, Kinugawa K, Inoue H, et al: Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra- short-acting β1-selective blocker landiolol with digoxin (J-Land Study). Circ J. 2013;77:908-916.
24. Sezai A, Osaka S, Yaoita H, et al. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial. J Thorac Cardiovasc Surg. 2015;150:957-964.
25. Ikea T, Shiga T, Shimizu W, et al. Efficacy and Safety of the Ultra-Short-Acting β1- Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study. Circ J. 2019;83:1456-1462.
26. Kakihana Y, Nishida O, Taniguchi T, et al. Efficacy and safety of landiolol, an ultra-short- acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;8:863-872.
27. Maehata Y, Nishigaki K, Kawahira Y, et al. The efficacy of landiolol against junctional ectopic tachycardia after pediatric cardiac surgery – A novel treatment of ultra-short- acting beta-adrenergic blocker in congenital heart disease – report of two cases. Prog Med. 2011;31:601-604 (in Japanese).
28. Tokunaga C, Hiramatsu Y, Kanemoto S, et al. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery. Ann Thorac Surg. 2013;95:1685-1688.
29. Oka H, Sugimoto M, Azuma H. Efficacy of landiolol for the treatment of junctional ectopic tachycardia resulting from sepsis. Cardiol Young. 2016;26:183-187.
30. Fujita S, Futatani T, Kubo T, et al. Virus myocarditis in a 1-month-old boy presenting as two types of paroxysmal supraventricular tachycardia. Pediatr Int. 2017;59:627-632.
31. Nakagawa R, Fujita S, Shimao A, et al. Successful treatment of neonatal idiopathic ventricular tachycardia with landiolol hydrochloride. Pediatr Int. 2019;61:1048-1050.
32. Sumitomo N, Horigome H, Miura M, et al. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial. J Cardiol. 2017;70:232-237.
33. Yoneyama F, Matsubara M, Sakamoto H, et al. Interventricular septal hematoma associated with congenital heart surgery: A case report and literature review. J Thorac Cardiovasc Surg. 2017;153:e55-e57.
34. Till JA, Ho SY, Rowland E. Histopathological findings in three children with His bundle tachycardia occuring subsequent to cardiac surgery. Eur Heart J. 1992;13:709-712.
35. Villain E, Vetter VL, Garcia JM, et al. Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation. 1990;81:1544- 1549.
36. Collins KK, Van Hare GF, Kertesz NJ, et al. Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol. 2009;53:690-697.
37. Zampi JD, Hirsch JC, Gurney JG, et al. Junctional ectopic tachycardia after infant heart surgery: incidence and outcomes. Pediatr Cardiol. 2012;33:1362-1369.
38. Baron AL, Moffett BS, Valdes SO, et al. Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr. 2015;166:115-8.
39. Pickoff AS, Zies L, Ferrer PL, et al. High-dose propranolol therapy in the management of supraventricular tachycardia. J Pediatr. 1979;94:144-146.
40. Ostman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol. 1999;34:1813-1822.
41. Gillette P, Garson A Jr, Eterovic E, et al. Oral propranolol treatment in infants and children. J Pediatr. 1978;92:141-144.
42. Mahmoud AB, Tantawy AE, Kouatli AA, et al. Propranolol: a new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot. Interact Cardiovasc Thorac Surg. 2008;7:184-187.
43. Nicastro ES, Majdalani MG, Abello MS, et al. Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year. Arch Argent Pediatr. 2020;118:273-276.
44. Sasao J, Tarver SD, Kindscher JD, et al. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985-989.
45. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol. 1999;34:70-77.
46. Beaty RS, Moffett BS, Hall S, et al: Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Pediatr Cardiol. 2015;36:1465- 1659.
47. Adamson PC, Rhodes LA, Saul JP, et al. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol. 2006;27:420-427.
48. Murakami M, Furuie H, Matsuguma K, et al. Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers. Drug Metab Pharmacokinet. 2005;20:337- 344.
49. Perry JC, McQuinn RL, Smith RT Jr, et al. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. J Am Coll Cardiol. 1989;14:185-191.
50. Perry JC, Garson A Jr. Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing. Am Heart J. 1992;124:1614- 1621.
51. Apostolakis S, Oeff M, Tebbe U, et al. Flecainide acetate for the treatment of atrial and ventricular arrhythmias. Expert Opin Pharmacother. 201;14:347-357.
52. Bronzetti G, Formigari R, Giardini A, et al. Intravenous flecainide for the treatment of junctional ectopic tachycardia after surgery for congenital heart disease. Ann Thorac Surg. 2003;76:148-151.
53. Imamura T, Tanaka Y, Ninomiya Y, et al. Combination of flecainide and propranolol for congenital junctional ectopic tachycardia. Pediatr Int. 2015;57:716-8.
54. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.
55. Leenhardt A, Glaser E, Burguera M, et al. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation. 1994;89:206-215.
56. Moffett BS, Valdes SO, Lupo PJ, et al. Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015;36:146-150.
57. Kovacikova L, Hakacova N, Dobos D, et al. Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. Ann Thorac Surg. 2009;88:616-622.
58. Haas NA, Camphausen CK. Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. J Thorac Cardiovasc Surg. 2008;136:1215-1222.
59. Raja P, Hawker RE, Chaikitpinyo A, et al. Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. Br Heart J. 1994.;72:261-265.
60. Laird WP, Snyder CS, Kertesz NJ, et al. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children. Pediatr Cardiol. 2003;24:133-137.
61. Imamura M, Dossey AM, Garcia X, et al. Prophylactic amiodarone reduces junctional ectopic tachycardia after tetralogy of Fallot repair. J Thorac Cardiovasc Surg. 2012;143:152-156.
62. Amrousy DE, Elshehaby W, Feky WE, et al. Safety and Efficacy of Prophylactic Amiodarone in Preventing Early Junctional Ectopic Tachycardia (JET) in Children After Cardiac Surgery and Determination of Its Risk Factor. Pediatr Cardiol. 2016;37:734-739.
63. Hasegawa T, Oshima Y, Maruo A, et al. Landiolol for junctional ectopic tachycardia refractory to amiodarone after pediatric cardiac surgery. Gen Thorac Cardiovasc Surg. 2013;61:350-352.
64. Sasaki T, Nemoto S, Ozawa H, et al. Successful administration of nifekalant hydrochloride for postoperative junctional ectopic tachycardia in congenital cardiac surgery. Kyobu Geka. 2007;60:1022-1026.
65. Aoki H, Suzuki T, Matsui H, et al. Efficacy of a pure Ikr blockade with nifekalant in refractory neonatal congenital junctional ectopic tachycardia and careful attention to damaging the atrioventricular conduction during the radiofrequency catheter ablation in infancy. HeartRhythm Case Rep. 2017;3:298-301.
66. Saiki H, Nakagawa R, Ishido H, et al. Landiolol hydrochloride infusion for treatment of junctional ectopic tachycardia in post-operative paediatric patients with congenital heart defect. Europace. 2013;15:1298-1303.
67. Barker GM, Affolter J, Saenz J, et al. Temporary atrial pacing for cardiac output after pediatric cardiac surgery. Pediatr Cardiol. 2013;34:1605-1611.
68. Hayashi J, Yoshimura Y, Uchida T, et al. M. Use of landiolol hydrocholoride to control tachycardia during pediatric cardiac surgery. Heart’s Original 2013;45:1531-1537.
69. Miyake K, Fujita Y, Yoshizawa S, et al. Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study. J Anesth. 2016;30:331-336.
70. Connolly SJ, Dorian P, Roberts RS, et al; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295:165- 171.